Tong SJ - Search Results

1

The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study.

Wu YS, Zhang N, Liu SH, Xu JF, Tong SJ, Cai YH, Zhang LM, Bai PD, Hu MB, Jiang HW, Na R, Ding Q, Sun YH. Wu YS, et al. Among authors: tong sj. Asian J Androl. 2016 Nov-Dec;18(6):925-929. doi: 10.4103/1008-682X.181192. Asian J Androl. 2016. PMID: 27212127 Free PMC article.

2

Prostate-specific antigen kinetics under androgen deprivation therapy and prostate cancer prognosis.

Zhang LM, Jiang HW, Tong SJ, Zhu HQ, Liu J, Ding Q. Zhang LM, et al. Among authors: tong sj. Urol Int. 2013;91(1):38-48. doi: 10.1159/000345939. Epub 2013 Jun 11. Urol Int. 2013. PMID: 23774685

3

Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population.

Wu YS, Wu XB, Zhang N, Jiang GL, Yu Y, Tong SJ, Jiang HW, Mao SH, Na R, Ding Q. Wu YS, et al. Among authors: tong sj. Asian J Androl. 2018 Jul-Aug;20(4):324-329. doi: 10.4103/aja.aja_81_17. Asian J Androl. 2018. PMID: 29405172 Free PMC article.

4

Outcomes and trends of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011.

Na R, Jiang H, Kim ST, Wu Y, Tong S, Zhang L, Xu J, Sun Y, Ding Q. Na R, et al. PLoS One. 2012;7(11):e49914. doi: 10.1371/journal.pone.0049914. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189170 Free PMC article.

5

Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?

Ding W, Chen Z, Gou Y, Sun C, Xu K, Tan J, Tong S, Xia G, Ding Q. Ding W, et al. Cancer Epidemiol. 2014 Apr;38(2):157-61. doi: 10.1016/j.canep.2014.02.001. Epub 2014 Mar 11. Cancer Epidemiol. 2014. PMID: 24629527

6

Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J. Ding G, et al. Prostate. 2015 Jun 15;75(9):957-68. doi: 10.1002/pros.22978. Epub 2015 Feb 25. Prostate. 2015. PMID: 25728945

7

miR-181 regulation of BAX controls cisplatin sensitivity of prostate cancer cells.

Cai ZP, Tong SJ, Wu YP, Qu LX, Ding Q. Cai ZP, et al. Among authors: tong sj. Int J Clin Exp Pathol. 2017 Sep 1;10(9):10127-10133. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966904 Free PMC article.

8

Cullin-1 promotes cell proliferation via cell cycle regulation and is a novel in prostate cancer.

Jiang H, He D, Xu H, Liu J, Qu L, Tong S. Jiang H, et al. Int J Clin Exp Pathol. 2015 Feb 1;8(2):1575-83. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25973042 Free PMC article.

9

Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups.

Ding W, Tong S, Gou Y, Sun C, Wang H, Chen Z, Tan J, Xu K, Xia G, Ding Q. Ding W, et al. World J Urol. 2015 Dec;33(12):1951-7. doi: 10.1007/s00345-015-1557-9. Epub 2015 Apr 18. World J Urol. 2015. PMID: 25894367

10

Primitive neuroectodermal tumor of the kidney: case report and review of literature.

Sun C, Du Z, Tong S, Xu K, Ding W, Sun J, Ding Q. Sun C, et al. World J Surg Oncol. 2012 Dec 27;10:279. doi: 10.1186/1477-7819-10-279. World J Surg Oncol. 2012. PMID: 23270507 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters